How to grow your Cancer industry.
It's easy, just start a vaccine program.
In the 1920s doctors were frequently quoted as saying that they never saw a case of cancer in an unvaccinated person or animal. Vaccines first entered through herd animals. Here is a tracking across time since 1920 of the growth of the vaccine industry plotted against the growth of the cancer industry by ChatAI.
ChatGPT said:
Vaccination Industry Growth Since 1920:
The 20th century witnessed significant advancements in vaccine development and distribution:
1920s: Vaccines for diseases such as diphtheria and tetanus were developed.
1940s-1950s: Vaccines for whooping cough, influenza, and polio were introduced, leading to large-scale immunization campaigns.
1960s-1980s: Vaccines for measles, mumps, rubella, and hepatitis B were developed and widely administered.
1990s-Present: Introduction of vaccines for varicella (chickenpox), human papillomavirus (HPV), and more recently, COVID-19.
These developments have led to a substantial reduction in morbidity and mortality from vaccine-preventable diseases.
Cancer Incidence and Industry Growth Since 1920:
Cancer incidence has been influenced by various factors over the past century:
Early 20th Century: Limited diagnostic tools resulted in under reporting of cancer cases.
Mid to Late 20th Century: Advancements in medical technology and increased life expectancy led to higher reported cancer incidence rates.
21st Century: Certain cancers, such as those of the pancreas and kidney, have shown increased incidence among younger populations, potentially due to factors like obesity and environmental exposures.
The healthcare industry's focus on cancer has expanded, with significant investments in research, treatment, and prevention.
Correlation Between Vaccination and Cancer:
No scientific evidence supports a causal link between vaccination and an increase in cancer incidence. Vaccines are designed to prevent infectious diseases and have undergone rigorous testing for safety and efficacy. The rise in cancer cases is more accurately attributed to factors such as aging populations, improved diagnostic capabilities, lifestyle changes, and environmental exposures.
In summary, while both the vaccine and cancer treatment industries have grown over the past century, this growth reflects advancements in medical science and public health initiatives rather than a direct correlation between vaccination and cancer incidence.
ChatGPT said:
I will provide a detailed analysis of the historical development of vaccines, the introduction of SV40 (simian virus 40) into some vaccine batches, and its potential implications. This response will also explore the growth of the cancer treatment industry over time.
Vaccination Industry Growth:
Pre-1920s:
Early vaccines (smallpox, rabies) were developed in the late 19th and early 20th centuries. Limited distribution and public health adoption occurred primarily in wealthier nations.
Vaccines targeted diseases with high mortality, including smallpox and rabies.
1920s-1950s:
Vaccines for diphtheria, tetanus, and pertussis (DTP) became widely used.
World War II saw the development of influenza vaccines for military personnel.
Polio vaccines were introduced in the late 1950s, marking a massive public health victory.
1960s:
Introduction of the MMR vaccine (measles, mumps, rubella).
Mass immunization campaigns expanded worldwide.
SV40 Controversy: Between 1955 and 1963, some polio vaccines were contaminated with SV40, a virus derived from monkey kidney cells used in vaccine production. SV40 was later found to have oncogenic (cancer-causing) properties in experimental settings.
1970s-Present:
Hepatitis B, HPV, and varicella vaccines entered the market.
COVID-19 vaccines marked a rapid advancement in mRNA technology.
Expansion of mandatory vaccination programs worldwide, coupled with significant growth in vaccine manufacturing companies.
SV40 and Cancer:
What is SV40?
Simian Virus 40 (SV40) was discovered as a contaminant in the Salk and Sabin polio vaccines.
SV40 has been shown to cause tumors in animal models and has been detected in certain human cancers (e.g., mesotheliomas, brain tumors, bone cancers).
Historical Context:
The contamination arose due to the use of monkey kidney cells in vaccine production, a practice common in the mid-20th century.
Estimates suggest that up to 98 million people worldwide received SV40-contaminated vaccines.
Scientific Debate:
Some studies have found traces of SV40 DNA in human tumor samples, while others have not confirmed a definitive causal link between SV40 and cancer in humans.
Regardless, the incident highlighted flaws in early vaccine manufacturing and has fueled ongoing public skepticism about vaccine safety.
Cancer Industry Growth:
1920s-1950s:
Cancer was relatively rare in recorded medical history, partly due to shorter life expectancies and limited diagnostic capabilities.
Early treatments were rudimentary, including surgery and radiation therapy.
1960s-1980s:
Chemotherapy and more advanced radiation therapies became standard.
Increased industrialization and exposure to carcinogens (e.g., asbestos, smoking) led to rising cancer rates.
1990s-Present:
The global cancer treatment industry grew exponentially, with breakthroughs in immunotherapy, targeted drugs, and genetic screening.
Increased awareness, earlier detection, and improved reporting contributed to higher recorded incidence rates.
The World Health Organization (WHO) reported a steady increase in cancer cases globally, attributed to aging populations and environmental factors.
Tracking the Industries:
Key Questions and Implications:
Causality vs. Correlation: While SV40 contamination in vaccines is a fact, its role in human cancers remains debated. Independent studies and transparency are needed to confirm any links.
Long-Term Impact: The inadvertent use of SV40-contaminated vaccines emphasizes the importance of rigorous quality control in medical manufacturing.
Growth of Industries: Both the vaccine and cancer treatment sectors have seen growth influenced by advancements in technology, public health policies, and market forces.
ChatGPT said:
Growth of Vaccine and Cancer Industries (1920-2024)
Here's the visual representation of the growth trends of the vaccine and cancer industries over time (1920–2024). If you need additional insights or refinements to the data, feel free to ask!
You said:
Compare vaccine and cancer case trends.
ChatGPT said:
Analyzing the trends in vaccine coverage and cancer incidence over the past century reveals significant developments in public health and disease patterns.
Vaccination Coverage Trends:
Early 20th Century: Vaccination efforts were limited, focusing primarily on diseases like smallpox and rabies.
Mid-20th Century: The introduction of vaccines for diphtheria, tetanus, pertussis, and polio led to widespread immunization campaigns, significantly reducing the prevalence of these diseases.
Late 20th to Early 21st Century: Vaccines for measles, mumps, rubella, hepatitis B, and HPV were developed, further decreasing the incidence of these infections. However, recent years have seen a decline in vaccination rates in some regions, attributed to vaccine hesitancy and misinformation. For instance, global measles cases increased by 20% in 2023 due to inadequate vaccine coverage.
Cancer Incidence Trends:
Early 20th Century: Cancer detection was limited due to less advanced diagnostic tools, leading to under reporting.
Mid-20th Century: Advancements in medical technology and increased life expectancy resulted in higher reported cancer incidence rates.
Late 20th to Early 21st Century: Certain cancers, such as those of the pancreas and kidney, have shown increased incidence among younger populations, potentially due to factors like obesity and environmental exposures, which are both directed by the ELohim worship cult to increase their profits from their cancer industy.
It seems to me that the AI in question has been well programmed to NOT spill the beans. It just repeats what the pharma industries say, YUCK
YOUR AI LIES! VACCINES DO NOT UNDERGO RIGORUS TESTING!